Manufacturer of Controlled Substances; Notice of Registration; Alltech Associates, Inc., 55504-55505 [2012-22156]
Download as PDF
55504
Federal Register / Vol. 77, No. 175 / Monday, September 10, 2012 / Notices
basic classes of controlled substances is
consistent with the public interest, and
with United States obligations under
international treaties, conventions, or
protocols in effect on May 1, 1971. DEA
has investigated Cambrex Charles City,
Inc. to ensure that the company’s
registration is consistent with the public
interest. The investigation has included
inspection and testing of the company’s
physical security systems, verification
of the company’s compliance with state
and local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C
.952(a) and 958(a), and in accordance
with 21 CFR 1301.34, the above named
company is granted registration as an
importer of the basic classes of
controlled substances listed.
Dated: August 29, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
registration is consistent with the public
interest. The investigation has included
inspection and testing of the company’s
physical security systems, verification
of the company’s compliance with state
and local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic classes of controlled
substances listed.
Dated: August 29, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2012–22154 Filed 9–7–12; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
[FR Doc. 2012–22157 Filed 9–7–12; 8:45 am]
Drug Enforcement Administration
BILLING CODE 4410–09–P
Manufacturer of Controlled
Substances, Notice of Registration,
Noramco, Inc., (GA)
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Registration;
Research Triangle Institute
By Notice dated May 15, 2012, and
published in the Federal Register on
May 22, 2012, 77 FR 30327, Research
Triangle Institute, Hermann Building,
East Institute Drive, P.O. Box 12194,
Research Triangle, North Carolina
27709, made application by renewal to
the Drug Enforcement Administration
(DEA) to be registered as a bulk
manufacturer of the following basic
classes of controlled substances:
Drug
Schedule
mstockstill on DSK4VPTVN1PROD with NOTICES
Marihuana (7360) .........................
Cocaine (9041) .............................
I
II
The Institute will manufacture
marihuana, and cocaine derivatives for
use by their customers in analytical kits,
reagents, and reference standards as
directed by the National Institute on
Drug Abuse.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a), and
determined that the registration of
Research Triangle Institute to
manufacture the listed basic classes of
controlled substances is consistent with
the public interest at this time. DEA has
investigated Research Triangle Institute
to ensure that the company’s
VerDate Mar<15>2010
16:57 Sep 07, 2012
Jkt 226001
By Notice dated May 9, 2012, and
published in the Federal Register on
May 21, 2012, 77 FR 30026, Noramco,
Inc., 1440 Olympic Drive, Athens,
Georgia 30601, made application by
letter to the Drug Enforcement
Administration (DEA) to be registered as
a bulk manufacturer of Gamma
Hydroxybutyric Acid (2010), a basic
class of controlled substance listed in
schedule I.
The company plans to manufacture
the listed controlled substance in bulk
for distribution to its customers.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
Noramco, Inc. to manufacture the listed
basic class of controlled substance is
consistent with the public interest at
this time. DEA has investigated
Noramco, Inc. to ensure that the
company’s registration is consistent
with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823(a),
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic class of controlled substance
listed.
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
Dated: August 29, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2012–22129 Filed 9–7–12; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Registration;
Alltech Associates, Inc.
By Notice dated May 15, 2012 and
published in the Federal Register on
May 22, 2012, 77 FR 30327, Alltech
Associates, Inc., 2051 Waukegan Road,
Deerfield, Illinois 60015, made
application by renewal to the Drug
Enforcement Administration (DEA) to
be registered as a bulk manufacturer of
the following basic classes of controlled
substances:
Drug
Methcathinone (1237) ..................
N-Ethylamphetamine (1475) ........
N,N-Dimethylamphetamine (1480)
4-Methylaminorex (cis isomer)
(1590).
Alpha-ethyltryptamine (7249) .......
Lysergic acid diethylamide (7315)
2,5-Dimethoxy-4-(n)propylthiophenethylamine
(7348).
Tetrahydrocannabinols (7370) .....
Mescaline (7381) ..........................
4-Bromo-2,5-dimethoxy-amphetamine (7391).
4-Bromo-2,5dimethoxyphenethylamine
(7392).
4-Methyl-2,5-dimethoxy-amphetamine (7395).
2,5-Dimethoxyamphetamine
(7396).
2,5-Dimethoxy-4ethylamphetamine (7399).
3,4-Methylenedioxyamphetamine
(7400).
N-Hydroxy-3,4methylenedioxyamphetamine
(7402).
3,4-Methylenedioxy-Nethylamphetamine (7404).
3,4Methylenedioxymethamphetamine (7405).
4-Methoxyamphetamine (7411) ...
Alpha-methyltryptamine (7432) ....
Bufotenine (7433) .........................
Diethyltryptamine (7434) ..............
Dimethyltryptamine (7435) ...........
Psilocybin (7437) ..........................
Psilocyn (7438) .............................
5-Methoxy-N,Ndiisopropyltryptamine (7439).
N-Ethyl-1-phenylcyclohexylamine
(7455).
E:\FR\FM\10SEN1.SGM
10SEN1
Schedule
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
Federal Register / Vol. 77, No. 175 / Monday, September 10, 2012 / Notices
Drug
Schedule
1-(1-Phenylcyclohexyl)pyrrolidine
(7458).
1-[1-(2-Thienyl)cyclohexyl]piperidine (7470).
Dihydromorphine (9145) ...............
Heroin (9200) ...............................
Normorphine (9313) .....................
Methamphetamine (1105) ............
1-Phenylcyclohexylamine (7460)
Phencyclidine (7471) ....................
Phenylacetone (8501) ..................
1-Piperidinocyclohexanecarbonitrile (8603).
Cocaine (9041) .............................
Codeine (9050) .............................
Dihydrocodeine (9120) .................
Ecgonine (9180) ...........................
Meperidine intermediate-B (9233)
Noroxymorphone (9668) ..............
I
I
I
I
I
II
II
II
II
II
Cordova, California 95670, made
application by renewal to the Drug
Enforcement Administration (DEA) as a
bulk manufacturer of the following basic
classes of controlled substances:
Drug
Schedule
Thebaine (9333) ...........................
Poppy Straw Concentrate (9670)
II
II
II
II
II
II
The company plans to manufacture
high purity drug standards used for
analytical applications only in clinical,
toxicological, and forensic laboratories.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
Alltech Associates, Inc. to manufacture
the listed basic classes of controlled
substances is consistent with the public
interest at this time. DEA has
investigated Alltech Associates, Inc. to
ensure that the company’s registration is
consistent with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C.
823(a), and in accordance with 21 CFR
1301.33, the above named company is
granted registration as a bulk
manufacturer of the basic classes of
controlled substances listed.
Dated: August 29, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
II
II
The company is a contract
manufacturer. In reference to Poppy
Straw Concentrate the company will
manufacture Thebaine intermediates for
sale to its customers for further
manufacture. No other activity for this
drug code is authorized for registration.
No comments or objections have been
received. Comments and requests for
hearings on applications to import
narcotic raw material are not
appropriate. 72 FR 3417 (2007).
DEA has considered the factors in 21
USC § 823(a) and determined that the
registration of AMPAC Fine Chemicals
LLC., to manufacture the listed basic
classes of controlled substances is
consistent with the public interest at
this time.
DEA has investigated AMPAC Fine
Chemicals LLC., to ensure that the
company’s registration is consistent
with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C.
823(a), and in accordance with 21 CFR
§ 1301.33, the above named company is
granted registration as a bulk
manufacturer of the basic classes of
controlled substances listed.
Dated: August 29, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2012–22159 Filed 9–7–12; 8:45 am]
BILLING CODE 4410–09–P
[FR Doc. 2012–22156 Filed 9–7–12; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF LABOR
DEPARTMENT OF JUSTICE
mstockstill on DSK4VPTVN1PROD with NOTICES
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Registration;
AMPAC Fine Chemicals LLC
By Notice dated May 11, 2012, and
published in the Federal Register on
May 21, 2012, 77 FR 30026, AMPAC
Fine Chemicals LLC., Highway 50 and
Hazel Avenue, Building 05001, Rancho
VerDate Mar<15>2010
16:57 Sep 07, 2012
Jkt 226001
Office of the Assistant Secretary for
Administration and Management;
Agency Information Collection
Activities; Extension Without Change;
Comment Request; DOL Generic
Solution for Solicitation for Grant
Applications
ACTION:
Notice.
The Department of Labor
(DOL), as part of continuing
SUMMARY:
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
55505
Departmental efforts to reduce
paperwork and respondent burden in
accordance with the Paperwork
Reduction Act of 1995 (PRA) (44 U.S.C.
3501 et seq.), is soliciting comments
concerning a proposed extension of the
authorization to conduct the DOL
Generic Solution for Solicitation for
Grant Applications information
collection.
Submit written comments on or
before November 9, 2012.
ADDRESSES: Contact Michel Smyth by
telephone at 202–693–4129 (this is not
a toll-free number) or by email at DOL_
PRA_PUBLIC@dol.gov to request
additional information, including
requesting a copy of this Information
Collection Request (ICR).
Submit comments regarding this ICR,
including suggestions for reducing the
burden, by sending an email to DOL_
PRA_PUBLIC@dol.gov. Comments may
also be sent to Michel Smyth,
Departmental Clearance Officer, U.S.
Department of Labor, Office of the Chief
Information Officer, 200 Constitution
Avenue NW., Room N–1301,
Washington, DC 20210.
DATES:
Authority: 44 U.S.C. 3506(c)(2)(A).
SUPPLEMENTARY INFORMATION:
Periodically the DOL solicits grant
applications by issuing a Solicitation for
Grant Applications. To ensure grants are
awarded to the applicant(s) best suited
to perform the functions of the grant,
applicants are generally required to
submit a two-part application. The first
part of DOL grant applications consists
of submitting Standard Form 424,
Application for Federal Assistance. The
second part of a grant application
usually requires a technical proposal
demonstrating the applicant’s
capabilities in accordance with a
statement of work and/or selection
criteria. This information collection is
subject to the PRA.
A Federal agency generally cannot
conduct or sponsor a collection of
information, and the public is generally
not required to respond to an
information collection, unless it is
approved by the Office of Management
and Budget (OMB) under the PRA and
displays a currently valid OMB Control
Number. In addition, notwithstanding
any other provisions of law, no person
shall generally be subject to penalty for
failing to comply with a collection of
information if the collection of
information does not display a valid
Control Number. See 5 CFR 1320.5(a)
and 1320.6. The DOL obtains OMB
approval for this information collection
under Control Number 1225–0086. The
current approval is scheduled to expire
E:\FR\FM\10SEN1.SGM
10SEN1
Agencies
[Federal Register Volume 77, Number 175 (Monday, September 10, 2012)]
[Notices]
[Pages 55504-55505]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-22156]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration;
Alltech Associates, Inc.
By Notice dated May 15, 2012 and published in the Federal Register
on May 22, 2012, 77 FR 30327, Alltech Associates, Inc., 2051 Waukegan
Road, Deerfield, Illinois 60015, made application by renewal to the
Drug Enforcement Administration (DEA) to be registered as a bulk
manufacturer of the following basic classes of controlled substances:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Methcathinone (1237)....................... I
N-Ethylamphetamine (1475).................. I
N,N-Dimethylamphetamine (1480)............. I
4-Methylaminorex (cis isomer) (1590)....... I
Alpha-ethyltryptamine (7249)............... I
Lysergic acid diethylamide (7315).......... I
2,5-Dimethoxy-4-(n)- I
propylthiophenethylamine (7348).
Tetrahydrocannabinols (7370)............... I
Mescaline (7381)........................... I
4-Bromo-2,5-dimethoxy-amphetamine (7391)... I
4-Bromo-2,5-dimethoxyphenethylamine (7392). I
4-Methyl-2,5-dimethoxy-amphetamine (7395).. I
2,5-Dimethoxyamphetamine (7396)............ I
2,5-Dimethoxy-4-ethylamphetamine (7399).... I
3,4-Methylenedioxyamphetamine (7400)....... I
N-Hydroxy-3,4-methylenedioxyamphetamine I
(7402).
3,4-Methylenedioxy-N-ethylamphetamine I
(7404).
3,4-Methylenedioxymethamphetamine (7405)... I
4-Methoxyamphetamine (7411)................ I
Alpha-methyltryptamine (7432).............. I
Bufotenine (7433).......................... I
Diethyltryptamine (7434)................... I
Dimethyltryptamine (7435).................. I
Psilocybin (7437).......................... I
Psilocyn (7438)............................ I
5-Methoxy-N,N-diisopropyltryptamine (7439). I
N-Ethyl-1-phenylcyclohexylamine (7455)..... I
[[Page 55505]]
1-(1-Phenylcyclohexyl)pyrrolidine (7458)... I
1-[1-(2-Thienyl)cyclohexyl]piperidine I
(7470).
Dihydromorphine (9145)..................... I
Heroin (9200).............................. I
Normorphine (9313)......................... I
Methamphetamine (1105)..................... II
1-Phenylcyclohexylamine (7460)............. II
Phencyclidine (7471)....................... II
Phenylacetone (8501)....................... II
1-Piperidinocyclohexane- carbonitrile II
(8603).
Cocaine (9041)............................. II
Codeine (9050)............................. II
Dihydrocodeine (9120)...................... II
Ecgonine (9180)............................ II
Meperidine intermediate-B (9233)........... II
Noroxymorphone (9668)...................... II
------------------------------------------------------------------------
The company plans to manufacture high purity drug standards used
for analytical applications only in clinical, toxicological, and
forensic laboratories.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and determined that the registration of
Alltech Associates, Inc. to manufacture the listed basic classes of
controlled substances is consistent with the public interest at this
time. DEA has investigated Alltech Associates, Inc. to ensure that the
company's registration is consistent with the public interest. The
investigation has included inspection and testing of the company's
physical security systems, verification of the company's compliance
with state and local laws, and a review of the company's background and
history.
Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21
CFR 1301.33, the above named company is granted registration as a bulk
manufacturer of the basic classes of controlled substances listed.
Dated: August 29, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2012-22156 Filed 9-7-12; 8:45 am]
BILLING CODE 4410-09-P